ethinyl estradiol; levonorgestrel · Teva Branded Pharm · NDA 022262
Loseasonique
Earliest generic entry, as listed
5 Dec 2028
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 7855190. Only method-of-use patents remain, so a generic may carve out the protected indication and enter earlier.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 7855190 | use U-1 | 5 Dec 2028 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 022262 · 001 | tablet, oral | 0.02MG,0.1MG;0.01MG,N/A | 5 Dec 2028 |